Skip to main content

Table 3 Baseline characteristics

From: Validation of the ELAN-HF Score and self-care behaviour on the nurse-led heart failure clinic after admission for heart failure

  ELAN-HF score low or intermediate ELAN-HF score high or very high Overall
N 29 51 80
Gender = Female (%) 10 (34.5) 24 (47.1) 34 (42.5)
Age (mean (SD)) 72.2 (10.7) 76.5 (8.5) 74.9 (9.5)
BMI kg/m2 (mean (SD)) 26.6 (5.5) 27.1 (6.2) 26.9 (5.9)
History of DM (%) 6 (20.7) 13 (25.5) 19 (23.8)
History of COPD (%) 5 (17.2) 8 (15.7) 13 (16.2)
Atrial fibrillation at admission (%) 13 (44.8) 25 (49.0) 38 (47.5)
Admitted with ADHF in past year (%) 7 (24.1) 19 (37.3) 26 (32.5)
History of valvular disease (%) 20 (69.0) 34 (66.7) 54 (67.5)
Ischaemic aetiology (%) 14 (48.3) 27 (52.9) 41 (51.2)
Polyclinic patient (%) 1 (3.4) 15 (29.4) 16 (20.0)
NYHA class at discharge (%)
 II 5 (17.2) 7 (13.7) 12 (15.0)
 III 19 (65.5) 31 (60.8) 50 (62.5)
 III-IV 5 (17.2) 13 (25.5) 18 (22.5)
Left Ventricular Ejection Fraction (%)
 Preserved 11 (37.9) 20 (39.2) 31 (38.8)
 Moderately reduced 11 (37.9) 11 (21.6) 22 (27.5)
 Reduced 7 (24.1) 20 (39.2) 27 (33.8)
NT-proBNP at admission pg/ml (median [IQR]) 3440.0
[2617.0, 5241.0]
6781.0
[3884.5, 14,211.5]
5604.0
[3038.5, 10,005.2]
NT-proBNP at discharge pg/ml (median [IQR]) 1892.0
[728.0, 2376.0]
5942.0
[3056.5, 10,968.0]
3505.0
[1911.5, 7860.8]
NT-proBNP change % (mean (SD)) -57.9 (24.3) -6.1 (54.2) -24.8 (51.9)
ELAN-HF score (median [IQR]) 3.0 [2.0, 4.0] 6.0 [5.0, 7.0] 5.0 [3.8, 6.0]
ELAN-HF score risk category (%)
 Low 10 (34.5) 0 (0.0) 10 (12.5)
 Intermediate 19 (65.5) 0 (0.0) 19 (23.8)
 High 0 (0.0) 41 (80.4) 41 (51.2)
 Very high 0 (0.0) 10 (19.6) 10 (12.5)
EHFScBS-9 score normalized (median [IQR]) 61.1 [50.0, 75.0] 69.4 [61.1, 77.8] 68.1 [58.3, 77.8]
Outcome (%)
 Event-free 20 (69.0) 16 (31.4) 36 (45.0)
 Readmission 6 (20.7) 17 (33.3) 23 (28.7)
 Mortality 3 (10.3) 6 (11.8) 9 (11.2)
 Readmission and mortality 0 (0.0) 12 (23.5) 12 (15.0)
  1. BMI based on clinical measurements weight en length, SD standard deviation, COPD Chronical Obstructive Pulmonary Disease, DM Diabetes Mellitus, NYHA New York Heart Association; LVEF left ventricular ejection fraction, NT-proBNP N-terminal proB-type natriuretic peptide in pg/ml, IQR Interquartile range; ELAN-HF European collaboration on Acute decompensated Heart Failure, EHFScBS-9 European Heart Failure Self-care Behaviour Scale